| Pharmaceutical Information |
| Drug Name |
Rivastigmine |
| Drug ID |
BADD_D01955 |
| Description |
Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase. |
| Indications and Usage |
For the treatment of mild to moderate dementia associated with Parkinson's disease or of the Alzheimer's type. |
| Marketing Status |
approved; investigational |
| ATC Code |
N06DA03 |
| DrugBank ID |
DB00989
|
| KEGG ID |
D03822
|
| MeSH ID |
D000068836
|
| PubChem ID |
77991
|
| TTD Drug ID |
D0WY5Q
|
| NDC Product Code |
16714-117; 70710-1198; 72855-101; 0781-7304; 65372-1153; 82245-0107; 51956-0001; 51956-0002; 51991-898; 65162-826; 72855-102; 49706-1825; 0078-0503; 63629-2065; 65162-749; 65162-825; 0378-9072; 0781-7309; 12651-118; 64552-4021; 65015-819; 0078-0501; 63629-8846; 0378-9071; 70710-1196; 16714-115; 63629-2066; 50379-0014; 65862-982; 72855-100; 51956-0003; 51991-897; 51991-899; 0781-7313; 63629-2064; 0378-9070; 0078-0502; 16714-116; 63629-8807; 70710-1197 |
| UNII |
PKI06M3IW0
|
| Synonyms |
Rivastigmine | (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate | RivastigmineTartrate | Rivastigmine Hydrogen Tartrate | Hydrogen Tartrate, Rivastigmine | Tartrate, Rivastigmine Hydrogen | Exelon | ENA 713 | 713, ENA | SDZ ENA 713 | 713, SDZ ENA | ENA 713, SDZ | ENA-713 | ENA713 |
|
| Chemical Information |
| Molecular Formula |
C14H22N2O2 |
| CAS Registry Number |
123441-03-2 |
| SMILES |
CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
